Gonazon

RSS

azagly-nafarelin

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Gonazon has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 15/08/2012

Authorisation details

Product details
Name
Gonazon
Agency product number
EMEA/V/C/000075
Active substance
azagly-nafarelin
International non-proprietary name (INN) or common name
azagly-nafarelin
Species
  • Dogs
  • Salmonidae (Salmonid fish)
Anatomical therapeutic chemical veterinary (ATCvet) codes
QH01CA
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
20/07/2003
Contact address
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

22/07/2009 Gonazon - EMEA/V/C/000075 - IB/0005

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES

Therapeutic indication

Female salmonid fish such as Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), brown trout (Salmo trutta) and Arctic charr (Salvelinus alpinus)

Induction and synchronisation of ovulation for the production of eyed-eggs and fry.

Dogs (bitches)

Prevention of gonadal function in bitches via long term blockade of gonadotrophin synthesis.

Assessment history

How useful was this page?

Add your rating